Morgan Stanley’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Sell |
242,092
-239,740
| -50% | -$1.81M | ﹤0.01% | 4762 |
|
|
2025
Q1 | $3.65M | Sell |
481,832
-156,237
| -24% | -$1.18M | ﹤0.01% | 4191 |
|
|
2024
Q4 | $7.77M | Sell |
638,069
-35,303
| -5% | -$430K | ﹤0.01% | 3615 |
|
|
2024
Q3 | $11.3M | Sell |
673,372
-164,911
| -20% | -$2.76M | ﹤0.01% | 3339 |
|
|
2024
Q2 | $14.6M | Sell |
838,283
-314,361
| -27% | -$5.48M | ﹤0.01% | 2996 |
|
|
2024
Q1 | $19.6M | Sell |
1,152,644
-687,154
| -37% | -$11.7M | ﹤0.01% | 2709 |
|
|
2023
Q4 | $18.7M | Buy |
1,839,798
+1,556,382
| +549% | +$15.9M | ﹤0.01% | 3403 |
|
|
2023
Q3 | $2.56M | Sell |
283,416
-41,671
| -13% | -$377K | ﹤0.01% | 4231 |
|
|
2023
Q2 | $3.5M | Buy |
325,087
+159,139
| +96% | +$1.71M | ﹤0.01% | 4028 |
|
|
2023
Q1 | $1.7M | Sell |
165,948
-59,070
| -26% | -$604K | ﹤0.01% | 4555 |
|
|
2022
Q4 | $2.37M | Sell |
225,018
-63,262
| -22% | -$667K | ﹤0.01% | 4338 |
|
|
2022
Q3 | $3.7M | Sell |
288,280
-57,263
| -17% | -$734K | ﹤0.01% | 3942 |
|
|
2022
Q2 | $4.43M | Sell |
345,543
-152,332
| -31% | -$1.95M | ﹤0.01% | 3870 |
|
|
2022
Q1 | $5.21M | Buy |
497,875
+168,419
| +51% | +$1.76M | ﹤0.01% | 3647 |
|
|
2021
Q4 | $5.08M | Buy |
329,456
+258,657
| +365% | +$3.99M | ﹤0.01% | 3707 |
|
|
2021
Q3 | $1.6M | Buy |
70,799
+4,450
| +7% | +$101K | ﹤0.01% | 4746 |
|
|
2021
Q2 | $1.71M | Buy |
66,349
+65,964
| +17,134% | +$1.7M | ﹤0.01% | 4750 |
|
|
2021
Q1 | $16K | Buy |
+385
| New | +$16K | ﹤0.01% | 6793 |
|